Skip to content
Inciteful Med

The Roadmap to Diagnosis: Blood Markers and Specialized Imaging

Last updated:

Congenital hyperinsulinism (CHI) is diagnosed using a 'critical sample' blood test during a low blood sugar episode, checking for inappropriate insulin, low ketones, and low fatty acids. If confirmed, an 18F-DOPA PET/CT scan can identify if the CHI is focal and potentially curable with surgery.

Key Takeaways

  • • A 'critical sample' blood test taken during a low blood sugar episode is essential for diagnosing congenital hyperinsulinism.
  • • Doctors look for detectable insulin alongside abnormally low ketones and free fatty acids to confirm CHI.
  • • Because excess insulin blocks the brain from receiving both sugar and backup fuels, CHI carries a high risk of permanent brain injury if not treated quickly.
  • • A glucagon stimulation test that raises blood sugar significantly during a low episode is a strong indicator of the condition.
  • • An 18F-DOPA PET/CT scan is the gold standard imaging test used to locate focal CHI spots in the pancreas, which can sometimes be cured with surgery.

Diagnosing Congenital Hyperinsulinism (CHI) requires a precise set of tests, often referred to as a “critical sample.” Because the symptoms of low blood sugar (hypoglycemia) can look the same regardless of the cause, doctors must catch the body “in the act” during a low-sugar episode to see exactly how the hormones and fuels are behaving [1][2].

The ‘Critical Sample’ Logistics and Markers

The Critical Sample is typically obtained during a carefully controlled fasting test done in the hospital setting. The medical team safely watches your child’s blood sugar drop while having immediate treatments (like IV dextrose) ready to administer the moment the necessary blood is drawn [1].

When a child’s blood sugar drops below 50 mg/dL, the body should naturally stop producing insulin and start burning fat for energy. In CHI, this process is broken. Doctors look for three specific markers in the blood during a low episode to confirm the diagnosis:

  1. Inappropriate Insulin & C-peptide: Even if insulin levels look “normal” or low, any detectable insulin (typically >1.25 \u00b5U/mL) when blood sugar is low is “inappropriate” [3]. Because insulin can be hard to measure, doctors often check C-peptide (a byproduct of insulin production that stays in the blood longer than insulin, making it a more reliable marker). A level \u22650.5 ng/mL is highly specific for CHI [4].
  2. Low Ketones (Beta-hydroxybutyrate): Normally, when the brain runs out of glucose, the body breaks down fat into ketones (like beta-hydroxybutyrate) to use as an emergency backup fuel [5]. In CHI, the excess insulin actively blocks this process. A level <2000 \u00b5mol/L (or <2.0 mmol/L) during hypoglycemia is a hallmark of CHI [3][4].
  3. Low Free Fatty Acids (FFA): Insulin also stops the body from releasing fats from storage. A level <1500 \u00b5mol/L (or <1.5 mmol/L) suggests that insulin is “locking” the fat away [3][4].

Why this is dangerous: Because insulin blocks both glucose and ketones, the brain is left with no fuel at all. This “double hit”—no sugar and no backup fuel—is why CHI carries a high risk of permanent brain injury if not managed quickly [5][6].

The Gold Standard Imaging: 18F-DOPA PET/CT

Once CHI is confirmed by blood tests and genetic testing points toward a “focal” mutation, the 18F-DOPA PET/CT scan becomes the most important tool in your child’s care [7][8].

  • How it works: The child is given a special tracer (18F-DOPA) that is “eaten” by the overactive beta-cells in the pancreas. These cells then glow on the scan [9][10].
  • What it finds: It helps doctors distinguish between Diffuse CHI (where the whole pancreas glows) and Focal CHI (where only one specific spot glows) [7].
  • Success Rates: The scan is highly accurate, often exceeding 90% sensitivity in finding focal lesions [11]. Identifying a focal spot allows a surgeon to remove just that tiny area, which can cure the condition entirely [7][12].

Diagnostic Completeness Checklist

To ensure your child has a thorough workup, their diagnostic journey should include:

  • [ ] Critical Blood Sample: Measured when blood sugar is <50 mg/dL in a controlled setting (includes Insulin, C-peptide, Ketones, and Free Fatty Acids) [4].
  • [ ] Glucagon Stimulation Test: A test where the drug glucagon is given; a rise in blood sugar \u226530 mg/dL is a strong indicator of CHI [4].
  • [ ] Genetic Testing: Early testing for ABCC8, KCNJ11, and other genes is essential to guide imaging and treatment [13][14].
  • [ ] 18F-DOPA PET/CT Scan: Only if a “focal” mutation is suspected or if the child does not respond to standard medications [7].
  • [ ] Neurodevelopmental Baseline: An early assessment to monitor for any signs of brain injury from early lows [15][16].

Frequently Asked Questions

What is a critical sample blood test for CHI?
A critical sample is a specific set of blood tests drawn in a safe hospital setting while a child's blood sugar drops below 50 mg/dL. It measures insulin, C-peptide, ketones, and free fatty acids to see exactly how the body's hormones react during a hypoglycemic episode.
Why are ketones abnormally low in children with CHI?
Normally, the body breaks down fat into ketones to use as backup brain fuel when blood sugar drops. In CHI, excess insulin actively blocks this fat-burning process, leaving the brain without any energy source and increasing the risk of brain injury.
What does an 18F-DOPA PET/CT scan do for hyperinsulinism?
This specialized imaging scan uses a safe tracer that highlights overactive insulin-producing cells in the pancreas. It helps doctors see if the condition is diffuse throughout the whole pancreas or limited to a single focal spot that might be curable with surgery.
How does a glucagon stimulation test help diagnose CHI?
During a low blood sugar episode, doctors may administer a medication called glucagon. If the child's blood sugar subsequently rises by 30 mg/dL or more, it is a strong indicator that the excessive insulin production is caused by congenital hyperinsulinism.

Questions for Your Doctor

  • • What were the exact levels of insulin, beta-hydroxybutyrate (BHB), and free fatty acids (FFA) during the 'critical sample' when my child's blood sugar was low?
  • • Did the Glucagon Stimulation Test result in a blood sugar rise of 30 mg/dL or more?
  • • Is the insulin assay used by this lab sensitive enough to detect very low but still 'inappropriate' levels of insulin?
  • • If a paternal mutation was found, how soon can we schedule an 18F-DOPA PET/CT scan at a specialized center?
  • • What is the plan to protect my child's brain from injury while we wait for definitive imaging or surgery?
  • • How long do genetic test results typically take at this center, and how will they be communicated to us?

Questions for You

  • • Do I have a copy of my child's 'critical sample' blood results and genetic report to keep in a dedicated medical file?
  • • Have I asked the medical team to explain the difference between my child's results and those of a 'typical' baby with low blood sugar?
  • • Who is the primary point of contact for coordinating between the hospital and a specialized CHI center if we need a PET/CT scan?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Congenital hyperinsulinism : contributions of chemistry, therapeutic response, genetics and imaging].

    Vandendaele C, Kaschten S, Parent AS, Fudvoye J

    Revue medicale de Liege 2024; (79(3)):168-174.

    PMID: 38487911
  2. 2

    Congenital hyperinsulinism: localization of a focal lesion with 18F-FDOPA positron emission tomography.

    States LJ, Becker SA, De León DD

    Pediatric radiology 2022; (52(4)):693-701 doi:10.1007/s00247-021-05206-5.

    PMID: 34668049
  3. 3

    Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia.

    Sakakibara A, Hashimoto Y, Kawakita R, et al.

    Pediatric diabetes 2018; (19(2)):259-264 doi:10.1111/pedi.12548.

    PMID: 28597971
  4. 4

    Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children.

    Ferrara C, Patel P, Becker S, et al.

    The Journal of pediatrics 2016; (168()):212-219 doi:10.1016/j.jpeds.2015.09.045.

    PMID: 26490124
  5. 5

    Congenital hyperinsulinism in a newborn presenting with poor feeding.

    Mazloom K, Sanchez-Lara PA, Langston S, et al.

    SAGE open medical case reports 2022; (10()):2050313X221083174 doi:10.1177/2050313X221083174.

    PMID: 35371490
  6. 6

    Congenital hyperinsulinism.

    Velde CD, Reigstad H, Tjora E, et al.

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2023; (143(18)) doi:10.4045/tidsskr.23.0425.

    PMID: 38088279
  7. 7

    F-18 DOPA PET/CT in pediatric patients with hyperinsulinemic hypoglycemia: A correlation with genetic analysis.

    Sagar S, Arora G, Damle N, et al.

    Nuclear medicine communications 2022; (43(4)):451-457 doi:10.1097/MNM.0000000000001526.

    PMID: 35045547
  8. 8

    Early diagnosis of focal congenital hyperinsulinism: A fluorine-18-labeled l-dihydroxyphenylalanine positron emission tomography/computed tomography study.

    Burroni L, Palucci A, Biscontini G, Cherubini V

    World journal of nuclear medicine 2021; (20(4)):395-397 doi:10.4103/wjnm.wjnm_159_20.

    PMID: 35018160
  9. 9

    Functional Imaging of Paragangliomas with an Emphasis on Von Hippel-Lindau-Associated Disease: A Mini Review.

    Ilias I, Meristoudis G

    Journal of kidney cancer and VHL 2017; (4(3)):30-36 doi:10.15586/jkcvhl.2017.92.

    PMID: 28890865
  10. 10

    Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols.

    Fargette C, Imperiale A, Taïeb D

    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2022; (66(2)):141-147 doi:10.23736/S1824-4785.22.03450-1.

    PMID: 35343670
  11. 11

    18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.

    Christiansen CD, Petersen H, Nielsen AL, et al.

    European journal of nuclear medicine and molecular imaging 2018; (45(2)):250-261 doi:10.1007/s00259-017-3867-1.

    PMID: 29116340
  12. 12

    Intraoperative Ultrasound: A Tool to Support Tissue-Sparing Curative Pancreatic Resection in Focal Congenital Hyperinsulinism.

    Bendix J, Laursen MG, Mortensen MB, et al.

    Frontiers in endocrinology 2018; (9()):478 doi:10.3389/fendo.2018.00478.

    PMID: 30186238
  13. 13

    [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by 18F-DOPA-PET CT scanning].

    Zhang MY, Ni JW, Ge JJ, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2021; (59(10)):853-858 doi:10.3760/cma.j.cn112140-20210417-00326.

    PMID: 34587682
  14. 14

    Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.

    Ni J, Ge J, Zhang M, et al.

    European journal of pediatrics 2019; (178(8)):1161-1169 doi:10.1007/s00431-019-03408-6.

    PMID: 31218401
  15. 15

    Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques.

    Martino M, Sartorelli J, Gragnaniello V, Burlina A

    Frontiers in pediatrics 2022; (10()):901338 doi:10.3389/fped.2022.901338.

    PMID: 36210928
  16. 16

    Severe transient neonatal hyperinsulinism: First Peruvian case series.

    Virú-Loza MA, Bermudez-Paredes F, Arauco-Carhuas IM

    SAGE open medical case reports 2025; (13()):2050313X251347787 doi:10.1177/2050313X251347787.

    PMID: 40520083

This page explains diagnostic tests for congenital hyperinsulinism for educational purposes only. Always consult your pediatric endocrinologist or medical team for advice and assistance in interpreting your child's specific lab results.

Stay up to date

Get notified when new research about Congenital isolated hyperinsulinism is published.

No spam. Unsubscribe anytime.